Press Releases

02.19.2016

Pfizer Receives Expanded FDA Approval For IBRANCE (palbociclib) In HR+, HER2- Metastatic Breast Cancer

02.16.2016

WYETH REACHES AGREEMENT IN PRINCIPLE TO RESOLVE MEDICAID DRUG REBATE CLAIMS FOR 2001-2006 PERIOD FOR PROTONIX

02.09.2016

Pfizer Commends The FDA Advisory Committee’s Vote To Approve Proposed Biosimilar Infliximab, The First Biosimilar Monoclonal Antibody Reviewed, For All Eligible Indications

02.08.2016

Pfizer Names Executive Leadership Team for Combined Organization Upon Close of Proposed Allergan Transaction

02.04.2016

UI strikes agreement with Pfizer Inc. to develop potential cystic fibrosis gene therapy

02.02.2016

PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2015 RESULTS PROVIDES 2016 FINANCIAL GUIDANCE

02.01.2016

Bristol-Myers Squibb and Pfizer Sign Collaboration with Portola Pharmaceuticals to Develop and Commercialize Investigational Andexanet Alfa in Japan

01.25.2016

La Jolla Institute receives $5 million gift from Pfizer

01.20.2016

King’s College London signs licence and research agreement with Pfizer Inc. in the field of gene therapy

01.13.2016

California Institute for Biomedical Research (Calibr) Enters Worldwide Strategic Collaboration with Pfizer Inc.

01.11.2016

Schrödinger Announces Research Collaboration with Pfizer Inc.

01.11.2016

HemoShear Therapeutics Announces Next Stage of Safety Collaboration with Pfizer Inc.